Despite the rising prevalence of inflammatory bowel disease (IBD) among racial and ethnic underserved populations, disparities in diagnosis, treatment, and outcomes remain. Patients of color are more likely to present with more severe disease, sometimes with extraintestinal manifestations. However, even …
LGBTQIA+ patients struggle to engage with a health care system that is endlessly complex and almost completely unresponsive to their unique health needs. Medical students, student pharmacists, PA students, and nursing students receive very few LGBTQ+ curricular hours and report …
Recent advances in molecular classification of endometrial cancer (EC) have opened the door to better identification of adjuvant treatments that are more effective. Understanding how PD-L1 and PD-1 inhibitors contribute to improved efficacy in addition to standard of care in …
Patients with Alzheimer’s disease receiving amyloid-targeting treatments (ATTs) are at risk for improper evaluation of amyloid-related imaging abnormalities (ARIA) in emergency care settings. Emergency medicine clinicians currently have insufficient clinical guidance pertaining to ARIA and its presentation in these patients. …
Shared decision-making (SDM) is a collaborative effort between patients and clinicians to share evidence and consider options regarding health care decisions. SDM is a significant facet of chronic kidney disease (CKD) care and is especially relevant for anemia in CKD, …
Given the novelty of amyloid-targeting treatments (ATTs) for Alzheimer’s disease, health care professionals specializing in emergency medicine are unfamiliar with best practices for managing patients receiving ATTs who present to emergency settings with symptoms of amyloid-related imaging abnormalities (ARIA). These …